1. Home
  2. XMTR vs GYRE Comparison

XMTR vs GYRE Comparison

Compare XMTR & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XMTR
  • GYRE
  • Stock Information
  • Founded
  • XMTR 2013
  • GYRE 2002
  • Country
  • XMTR United States
  • GYRE United States
  • Employees
  • XMTR N/A
  • GYRE N/A
  • Industry
  • XMTR Industrial Machinery/Components
  • GYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • XMTR Technology
  • GYRE Health Care
  • Exchange
  • XMTR Nasdaq
  • GYRE Nasdaq
  • Market Cap
  • XMTR 1.0B
  • GYRE 1.1B
  • IPO Year
  • XMTR 2021
  • GYRE N/A
  • Fundamental
  • Price
  • XMTR $33.23
  • GYRE $10.95
  • Analyst Decision
  • XMTR Buy
  • GYRE
  • Analyst Count
  • XMTR 10
  • GYRE 0
  • Target Price
  • XMTR $34.33
  • GYRE N/A
  • AVG Volume (30 Days)
  • XMTR 812.7K
  • GYRE 129.2K
  • Earning Date
  • XMTR 02-27-2025
  • GYRE 11-13-2024
  • Dividend Yield
  • XMTR N/A
  • GYRE N/A
  • EPS Growth
  • XMTR N/A
  • GYRE N/A
  • EPS
  • XMTR N/A
  • GYRE N/A
  • Revenue
  • XMTR $525,128,000.00
  • GYRE $105,033,000.00
  • Revenue This Year
  • XMTR $19.61
  • GYRE $25.32
  • Revenue Next Year
  • XMTR $19.11
  • GYRE $12.95
  • P/E Ratio
  • XMTR N/A
  • GYRE N/A
  • Revenue Growth
  • XMTR 21.19
  • GYRE N/A
  • 52 Week Low
  • XMTR $11.08
  • GYRE $8.26
  • 52 Week High
  • XMTR $45.33
  • GYRE $26.37
  • Technical
  • Relative Strength Index (RSI)
  • XMTR 39.49
  • GYRE 48.93
  • Support Level
  • XMTR $32.21
  • GYRE $9.51
  • Resistance Level
  • XMTR $35.07
  • GYRE $11.11
  • Average True Range (ATR)
  • XMTR 2.17
  • GYRE 0.85
  • MACD
  • XMTR -1.33
  • GYRE 0.04
  • Stochastic Oscillator
  • XMTR 7.87
  • GYRE 29.33

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.

Share on Social Networks: